Latest News

  • PARTNERSHIPS

    20 Jan 2026

    GSK-RAPT Deal Points to Pharma’s Biologic Future

  • INSIGHTS

    19 Jan 2026

    US Fermentation Push Signals a Shift in Drug Supply Strategy

  • REGULATORY

    15 Jan 2026

    FDA Loosens CMC Rules to Speed Cell and Gene Therapies

  • PARTNERSHIPS

    13 Jan 2026

    Fermentation Partnerships Redefine Health Ingredients

Blockchain Gains Attention as Pharma Reconsiders Data Integrity

ALCOA+ data integrity framework illustrating principles for pharmaceutical manufacturing records

TECHNOLOGY

7 Jan 2026

Driven by ALCOA+ expectations, US pharma is exploring blockchain for data integrity. Proven in supply chains, its use in fermentation remains theoretical

The Quiet Revolution Brewing in Biologics

INSIGHTS

10 Nov 2025

The Quiet Revolution Brewing in Biologics

Thermo Fisher and 21st Bio fuel a transatlantic fermentation surge reshaping global biologics

Exterior view of FDA offices highlighting PreCheck program for faster plant approvals.

REGULATORY

14 Aug 2025

Can the FDA’s PreCheck End Costly Drug Launch Delays?

FDA’s PreCheck pilot accelerates drug plant reviews, boosting US biologics production and cutting costly launch delays.

Esteve headquarters symbolizing the company’s CDMO expansion into the U.S. pharma market.

PARTNERSHIPS

7 Aug 2025

From Barcelona to Chicago: Esteve Targets U.S. Drugmakers

Esteve acquires Regis to bring European CDMO expertise to US soil, boosting domestic drug ingredient development and manufacturing service...

Close-up of medicine vials representing the growing U.S. biosimilar market.

MARKET TRENDS

1 Aug 2025

The Biosimilar Boom That’s Rewriting U.S. Pharma

US payers drive biosimilar boom, pressuring fermentation drug makers to cut costs and boost domestic capacity.

Scientist analyzing samples under microscope in AI-powered biotech fermentation lab.

TECHNOLOGY

25 Jul 2025

AI Supercharges Fermentation: TAPI Boosts Output and Cuts Emissions

TAPI's AI-driven feed system lifts drug productivity by over 15% while shrinking its carbon footprint.

3D illustration of RNA strands symbolizing enzyme-based RNA drug manufacturing.

INSIGHTS

29 Jun 2025

The Enzyme Play That Could Rewrite RNA Manufacturing

New data shows Codexis’ enzyme-based process scaling RNA drug manufacturing with cleaner, faster results.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.